Viewing Study NCT05877859


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-27 @ 3:24 AM
Study NCT ID: NCT05877859
Status: RECRUITING
Last Update Posted: 2025-05-14
First Post: 2023-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module